Evidence map›Paper›PMID 27812215›Full record

ArticlePloS one2016

Paradoxical Sensitivity to an Integrated Stress Response Blocking Mutation in Vanishing White Matter Cells.

Yusuke Sekine, Alisa Zyryanova, Ana Crespillo-Casado, Niko Amin-Wetzel, Heather P Harding, David Ron

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Unfolded protein response in myelin disorders.Neural regeneration research · 2020
    Review
  9. Article
  10. Article
  11. Article
  12. RNA (New York, N.Y.) · 2018
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Yusuke SekineCambridge Institute for Medical Research, University of Cambridge, Cambridge, United Kingdom.ORCID http://orcid.org/0000-0003-0345-1416
Alisa ZyryanovaCambridge Institute for Medical Research, University of Cambridge, Cambridge, United Kingdom.ORCID http://orcid.org/0000-0002-9885-6012
Ana Crespillo-CasadoCambridge Institute for Medical Research, University of Cambridge, Cambridge, United Kingdom.ORCID http://orcid.org/0000-0002-7230-3188
Niko Amin-WetzelCambridge Institute for Medical Research, University of Cambridge, Cambridge, United Kingdom.ORCID http://orcid.org/0000-0002-4640-3724
Heather P HardingCambridge Institute for Medical Research, University of Cambridge, Cambridge, United Kingdom.ORCID http://orcid.org/0000-0002-7359-7974
David RonCambridge Institute for Medical Research, University of Cambridge, Cambridge, United Kingdom.ORCID http://orcid.org/0000-0002-3014-5636
University of Cambridge · GB

Funding

Wellcome Trust
6 · The paper itself

Abstract

The eukaryotic translation initiation factor eIF2B promotes mRNA translation as a guanine nucleotide exchange factor (GEF) for translation initiation factor 2 (eIF2). Endoplasmic reticulum (ER) stress-mediated activation of the kinase PERK and the resultant phosphorylation of eIF2's alpha subunit (eIF2α) attenuates eIF2B GEF activity thereby inducing an integrated stress response (ISR) that defends against protein misfolding in the ER. Mutations in all five subunits of human eIF2B cause an inherited leukoencephalopathy with vanishing white matter (VWM), but the role of the ISR in its pathogenesis remains unclear. Using CRISPR-Cas9 genome editing we introduced the most severe known VWM mutation, EIF2B4A391D, into CHO cells. Compared to isogenic wildtype cells, GEF activity of cells with the VWM mutation was impaired and the mutant cells experienced modest enhancement of the ISR. However, despite their enhanced ISR, imposed by the intrinsic defect in eIF2B, disrupting the inhibitory effect of phosphorylated eIF2α on GEF by a contravening EIF2S1/eIF2αS51A mutation that functions upstream of eIF2B, selectively enfeebled both EIF2B4A391D and the related severe VWM EIF2B4R483W cells. The basis for paradoxical dependence of cells with the VWM mutations on an intact eIF2α genotype remains unclear, as both translation rates and survival from stressors that normally activate the ISR were not reproducibly affected by the VWM mutations. Nonetheless, our findings support an additional layer of complexity in the development of VWM, beyond a hyperactive ISR.

Indexed as

MutationAmino Acid SequenceAnimalsBase SequenceCell LineCHO CellsCricetinaeCricetulusEndoplasmic Reticulum StressEukaryotic Initiation Factor-2BHumansRecombination, GeneticUnfolded Protein ResponseWhite MatterEukaryotic Initiation Factor-2B

Identifiers

PMID27812215
PMCPMC5094784
OpenAlexW2548342685

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.